Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$9.89 - $12.7 $32,449 - $41,668
-3,281 Reduced 23.53%
10,665 $130 Million
Q1 2022

May 11, 2022

SELL
$7.89 - $12.48 $9,428 - $14,913
-1,195 Reduced 7.89%
13,946 $101,000
Q4 2021

Feb 15, 2022

BUY
$9.82 - $12.44 $148,684 - $188,354
15,141 New
15,141 $175,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.71B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Guerra Pan Advisors, LLC Portfolio

Follow Guerra Pan Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guerra Pan Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guerra Pan Advisors, LLC with notifications on news.